Benzonatate 200 mg
- Product NDC
- 49483-947
- Requested package NDC
- 49483-947-01
- 11-digit product format
- 494830947
- Labeler code
- 49483
- Product ID
- 49483-947_5adfd35d-e709-e09a-e063-6394a90af04e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Benzonatate
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Labeler
- TIME CAP LABORATORIES, INC
- Application
- ANDA220298
- Marketing category
- ANDA
- Marketing start
- 2026-09-14
- Substance
- BENZONATATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A220298-001 | BENZONATATE | BENZONATATE | 100MG | CAPSULE / ORAL | AA | 2026-03-30 | |
| A220298-002 | BENZONATATE | BENZONATATE | 200MG | CAPSULE / ORAL | AA | 2026-03-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A220298-001 | AA |
| A220298-002 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220298-001 | BENZONATATE | 100MG | CAPSULE / ORAL | AA | 2026-03-30 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A220298-002 | BENZONATATE | 200MG | CAPSULE / ORAL | AA | 2026-03-30 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A220298-001 | BENZONATATE | 100MG | CAPSULE / ORAL | AA | 2026-03-30 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A220298-002 | BENZONATATE | 200MG | CAPSULE / ORAL | AA | 2026-03-30 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A220298-001 | BENZONATATE | 100MG | CAPSULE / ORAL | AA | 2026-03-30 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A220298-002 | BENZONATATE | 200MG | CAPSULE / ORAL | AA | 2026-03-30 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A220298-001 | BENZONATATE | 100MG | CAPSULE / ORAL | AA | 2026-03-30 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A220298-002 | BENZONATATE | 200MG | CAPSULE / ORAL | AA | 2026-03-30 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220298-001 | BENZONATATE | 100MG | CAPSULE / ORAL | AA | 2026-03-30 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220298-002 | BENZONATATE | 200MG | CAPSULE / ORAL | AA | 2026-03-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A220298-001 | AA | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A220298-002 | AA | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A220298-001 | AA | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A220298-002 | AA | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A220298-001 | AA | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A220298-002 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A220298-001 | AA | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A220298-002 | AA | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220298-001 | AA | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A220298-002 | AA | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Benzonatate 200 mg
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BENZONATATE | 200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5P4DHS6ENR | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5adfd324-b6d6-f624-e063-6294a90ab26e | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Benzonatate 100 mg | BENZONATATE | TIME CAP LABORATORIES, INC | 5adfd324-b6d6-f624-e063-6294a90ab26e | 2026-09-07 | Warnings, Adverse reactions | 220298 ANDA220298 49483-947-01 49483-947 49483094701 |
| Benzonatate 100 mg | BENZONATATE 100 MG | MARKSANS PHARMA LIMITED | 44104cfc-df60-4d48-9fe1-53456a5e1974 | 2026-04-10 | Warnings, Adverse reactions | 220298 ANDA220298 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 49483-947-01 | 49483094701 | 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (49483-947-01) | 2026-09-14 | No | No | Current |